Table 2.
Antifungal susceptibility profile of Hormographiella aspergillata clinical isolates reported in the literature (n = 16).
| 1st author [ref] N isolates Testing method |
Present case 1 isolate SYO |
Gené (1) 7 isolates BMiD |
Suarez (5) 1 isolate EUCAST |
Nanno (8) 1 isolate NA |
Bojic (12) 1 isolate E-test |
Conen (13) 3 isolates CLSI |
Verweij (14) 1 isolate Agar / BMaD |
Isabel Cristina (18) 1 isolate EUCAST |
|---|---|---|---|---|---|---|---|---|
| Itraconazole | 2 | 0.51 ± 0.1 | ≥8 | 0.25 | – | – | 32 / 8 | – |
| Voriconazole | 0.5 | – | 1 | 0.015 | 0.125 | 0.125 - 0.25 | 0.5 / NA | 0.06 |
| Posaconazole | 2 | – | – | – | 0.064 | 2 | – | 0.06 |
| Caspofungin | 0.5 | – | 2 | – | – | ≥32 | – | 32 |
| Anidulafungin | 0.12 | – | – | – | – | – | – | – |
| Micafungin | 0.25 | 2.3 ± 1.5 | – | ≥16 | – | – | – | – |
| Amphotericin B | 0.5 | 0.5/2.3 | 2 | 0.125 | 0.094 | 0.5 | 0.03 / 0.5 | 32 |
Values are minimum inhibitory concentration (MIC) expressed in mg/L.
SYO: Sensititre YeastOneTM; BMiD: broth microdilution; NA, not available; EUCAST: European Committee on antimicrobial susceptibility testing; CLSI: clinical and laboratory standards institute; BMaD: broth macrodilution.